You can find the annual or quarterly income statement of Dyne Therapeutics Inc here for insights into the performance and operational efficiency of Dyne Therapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

Operating expenses

7.79%113.89M

60.91%115.79M

76.95%122.37M

43.46%97.11M

69.67%105.66M

7.83%71.96M

52.11%69.16M

68.61%67.69M

47.29%62.27M

26.50%66.74M

27.05%45.46M

-22.74%40.15M

-1.14%42.28M

74.89%52.76M

42.37%35.78M

81.68%51.96M

216.32%42.77M

--30.16M

--25.13M

--28.60M

--13.52M

R&D expenses

4.76%97.22M

59.38%99.24M

139.00%106.45M

39.02%81.81M

67.96%92.80M

5.30%62.26M

18.66%44.54M

77.29%58.84M

59.36%55.25M

26.71%59.13M

32.94%37.54M

-21.54%33.19M

-5.04%34.67M

95.48%46.66M

51.60%28.24M

91.42%42.30M

277.21%36.51M

--23.87M

--18.63M

--22.10M

--9.68M

Depreciation, depletion, and amortization

19.41%523.00K

25.75%503.00K

25.50%502.00K

25.00%500.00K

1.62%438.00K

-7.19%400.00K

-2.91%400.00K

-0.25%400.00K

7.75%431.00K

-13.80%431.00K

-3.06%412.00K

0.25%401.00K

33.33%400.00K

100.80%500.00K

41.67%425.00K

84.33%400.00K

71.43%300.00K

--249.00K

--300.00K

--217.00K

--175.00K

Operating profit

-7.79%-113.89M

-60.91%-115.79M

-76.95%-122.37M

-43.46%-97.11M

-69.67%-105.66M

-7.83%-71.96M

-52.11%-69.16M

-68.61%-67.69M

-47.29%-62.27M

-26.50%-66.74M

-27.05%-45.46M

22.74%-40.15M

1.14%-42.28M

-74.89%-52.76M

-42.37%-35.78M

-81.68%-51.96M

-216.32%-42.77M

---30.16M

---25.13M

---28.60M

---13.52M

Net non-operating interest income (expenses)

Non-operating interest income

-8.62%8.48M

-6.06%6.63M

136.51%7.10M

333.58%7.59M

323.76%9.28M

219.53%7.05M

101.07%3.00M

30.48%1.75M

142.41%2.19M

400.45%2.21M

549.13%1.49M

637.36%1.34M

390.76%903.00K

110.00%441.00K

38.55%230.00K

468.75%182.00K

--184.00K

--210.00K

--166.00K

--32.00K

----

Non-operating interest expense

--2.90M

--94.00K

----

-100.00%0.00

--0.00

--81.00K

--130.00K

Other non-operating income (expenses)

137.60%279.00K

-731.77%-1.60M

-117.59%-89.00K

96.29%-26.00K

-488.89%-742.00K

48.53%-192.00K

334.26%506.00K

-2820.83%-701.00K

-1300.00%-126.00K

-3830.00%-373.00K

-620.00%-216.00K

-200.00%-24.00K

---9.00K

--10.00K

---30.00K

---8.00K

100.00%0.00

--0.00

----

--0.00

---270.00K

Income before tax

-11.24%-108.04M

-70.28%-110.86M

-75.72%-115.36M

-34.37%-89.54M

-61.31%-97.13M

-0.31%-65.10M

-48.57%-65.65M

-71.63%-66.64M

-45.49%-60.21M

-24.09%-64.90M

-24.18%-44.19M

25.02%-38.83M

2.81%-41.38M

-74.61%-52.30M

-42.51%-35.58M

-80.76%-51.79M

-205.91%-42.58M

---29.95M

---24.97M

---28.65M

---13.92M

Income after tax

-11.24%-108.04M

-70.28%-110.86M

-75.72%-115.36M

-34.37%-89.54M

-61.31%-97.13M

-0.31%-65.10M

-48.57%-65.65M

-71.63%-66.64M

-45.49%-60.21M

-24.09%-64.90M

-24.18%-44.19M

25.02%-38.83M

2.81%-41.38M

-74.61%-52.30M

-42.51%-35.58M

-80.76%-51.79M

-205.91%-42.58M

---29.95M

---24.97M

---28.65M

---13.92M

Net income from continuous operations

-11.24%-108.04M

-70.28%-110.86M

-75.72%-115.36M

-34.37%-89.54M

-61.31%-97.13M

-0.31%-65.10M

-48.57%-65.65M

-71.63%-66.64M

-45.49%-60.21M

-24.09%-64.90M

-24.18%-44.19M

25.02%-38.83M

2.81%-41.38M

-74.61%-52.30M

-42.51%-35.58M

-80.76%-51.79M

-205.91%-42.58M

---29.95M

---24.97M

---28.65M

---13.92M

Net income attributable to controlling interests

-11.24%-108.04M

-70.28%-110.86M

-75.72%-115.36M

-34.37%-89.54M

-61.31%-97.13M

-0.31%-65.10M

-48.57%-65.65M

-71.63%-66.64M

-45.49%-60.21M

-24.09%-64.90M

-24.18%-44.19M

25.02%-38.83M

2.81%-41.38M

-74.61%-52.30M

-42.51%-35.58M

-80.76%-51.79M

-205.91%-42.58M

---29.95M

---24.97M

---28.65M

---13.92M

Net income attributable to common shareholders

-11.24%-108.04M

-70.28%-110.86M

-75.72%-115.36M

-34.37%-89.54M

-61.31%-97.13M

-0.31%-65.10M

-48.57%-65.65M

-71.63%-66.64M

-45.49%-60.21M

-24.09%-64.90M

-24.18%-44.19M

25.02%-38.83M

2.81%-41.38M

-74.61%-52.30M

-42.51%-35.58M

-80.76%-51.79M

-205.91%-42.58M

---29.95M

---24.97M

---28.65M

---13.92M

Basic earnings per share

20.87%-0.76

-38.33%-0.97

-29.57%-1.05

19.13%-0.88

2.28%-0.96

35.12%-0.70

-3.26%-0.81

-47.63%-1.09

-23.31%-0.99

-7.17%-1.08

-13.77%-0.78

26.84%-0.73

3.70%-0.80

-73.04%-1.01

-36.64%-0.69

-73.75%-1.00

-159.80%-0.83

---0.58

---0.50

---0.58

---0.32

Diluted earnings per share

20.87%-0.76

-38.33%-0.97

-29.57%-1.05

19.13%-0.88

2.28%-0.96

35.12%-0.70

-3.26%-0.81

-47.63%-1.09

-23.31%-0.99

-7.17%-1.08

-13.77%-0.78

26.84%-0.73

3.70%-0.80

-73.04%-1.01

-36.64%-0.69

-73.75%-1.00

-159.80%-0.83

---0.58

---0.50

---0.58

---0.32

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

